Dr. Giovanna Panzeca is a postdoctoral researcher in medicinal chemistry. She earned her Master's degree in Pharmaceutical Chemistry and Technology (cum laude) from the University of Palermo. Following her graduation, she held an 18-month research fellowship at the National Research Council (CNR) in Palermo, focusing on the synthesis and characterization of heterocyclic scaffolds with anticancer and antioxidant properties. Between 2019 and 2022, she pursued a PhD in Molecular and Biomolecular Sciences at the University of Palermo—conferred with the Doctor Europaeus label—specializing in protein kinase inhibitors and the synthesis of nature-inspired analogues. During her doctoral tenure, she spent five months as a visiting researcher at the Cancer Center Amsterdam (Amsterdam UMC), performing biological evaluations on pancreatic ductal adenocarcinoma (PDAC) cell lines. Since 2023, she has been a postdoctoral researcher at the University of Siena, focusing on the design of novel therapeutic agents for rare and infectious diseases, as well as peptide-based therapeutics for oncology. Notably, she co-first authored a 2026 review in Medicinal Research Reviews on FLT3 inhibitors for acute myeloid leukemia. Alongside her research, she actively mentors thesis students, has presented her work at national and international conferences, and was awarded the Best Poster Prize at EAMHC 2019.
University of Siena
Siena, Tuscany, Italy
DBCF
Best Poster Award EAMHC2019
Società Chimica Italiana, Rome, Italy
10th EurAsian Meeting on Heterocyclic Chemistry (EAMHC-2019)
Post Doctoral Researcher
University of Siena, Siena, Italy
01 Feb 2023 - present
Research or Laboratory Scientist
Cancer Center Amsterdam, Amsterdam, The Netherlands
01 Jun 2022 - 31 Oct 2022
Research or Laboratory Scientist
University of Palermo, Palermo, Italy
01 Nov 2019 - 31 Oct 2022
Research or Laboratory Scientist
ISMN-CNR, Institute for the Study of Nanostructured Materials, Palermo, Italy
03 Apr 2018 - 02 Oct 2019